Session 2: Platelet aggregation – investigating a suspected platelet function disorder

Speakers: José Rivera

José Rivera
Dr. Jose Rivera Pozo obtained a degree in Chemistry at the University of Murcia in 1985 and a PhD in Biochemistry at the University of Valencia in 1990. Since 1991 he is member of the staff at the Blood Transfusion Centre of Murcia (CRH), where he is responsible of the Quality System and blood processing departments. Dr. River is also Associate Professor at the Department of Internal Medicine of the University of Murcia (Spain) and senior investigator of the Biomedical Research institute of Murcia (IMIB) and the Spanish Network of Rare Diseases (CIBERER).

At the CRH he leads the research areas of blood component processing as well as basic and clinical research in platelet physiology and pathology.

He has published around 150 articles in international peer-reviewed journals (Blood, JTH, T&H, Haematologica, Transfusion, Vox Sanguinis, Platelets, etc.), and presented more than 250 communications in national and international congresses (Index h:34, according to Scopus; h:41, according to Google Academico; 03/04/2023). His publications are available at https://orcid.org/0000-0003-4225-6840.

He has supervised twenty Doctoral and Master Thesis achieving maximal qualification and has gained several research prizes in Spain.

During this career, he has been the principal investigator in around twenty research projects granted by Public and private organizations, leading currently three of them.

In 2015-2019, he was one of the co-chairs of the Platelet Physiology Subcommittee of the International Society of Thrombosis and Hemostasis (ISTH). He is member of the ISTH, the Spanish Societies of Hematology (SEHH), Thrombosis & Haemostasis (SETH) and blood Transfusion (SETS), the Working Group on Blood Processing of the SETS, and the Platelet Disorders expert panel of CLinGen. Since 2008 he leads the Spanish Working Group on Diagnosis & Study of Inherited Platelet Disorders (GEAPC) and the Spanish Registry of Inherited Platelet Disorders (RETPLAC).

Nowadays, he has ongoing, multiple national and international research collaborations in the platelet field.